Wednesday, August 12, 2026

Utah man indicted on drug and firearm charges following task force investigation

A Duchesne man has been indicted on drug distribution and firearm charges after authorities seized bath salts ingredients and a
X / Twitter
LinkedIn
Print

A federal grand jury in Salt Lake City indicted Bronson Gary Dean, 51, of Duchesne, Utah, on July 22 for alleged drug and firearm offenses after agents seized approximately 351.8 grams of alpha-pyrrolidinopentiophenone (Alpha-PVP), the main illicit substance found in “bath salts,” and a handgun which Dean is prohibited from possessing.

According to court documents, North Salt Lake Police stopped Dean’s pickup truck on February 23 after observing a traffic violation. Officers said they observed what appeared to be drug paraphernalia inside the vehicle. A search revealed additional paraphernalia including baggies, a digital scale with powder residue, suspected marijuana, and a backpack containing more baggies with a yellowish granular substance as well as a black .45 caliber Kahr CW45 handgun reported stolen. Officers also found laboratory-grade glassware and unknown liquids among various labeled chemical containers.

The Drug Enforcement Administration Clandestine Lab Team responded to the scene. Agents determined that the glassware and chemicals were used in manufacturing synthetic cathinones (“bath salts”). Samples sent to the DEA Southwest Laboratory confirmed the presence of 351.8 grams of Alpha-PVP, which is classified as a schedule I controlled substance.

Dean faces charges for being a felon in possession of a firearm and possession of α-Pyrrolidinopentiophenone with intent to distribute. His initial appearance is scheduled for July 27 at the Orrin G. Hatch United States Courthouse before a U.S. Magistrate Court Judge.

United States Attorney Melissa Holyoak announced that the case is being investigated by the U.S. Drug Enforcement Administration and Salt Lake Metro Narcotics Task Force with significant assistance from North Salt Lake Police Department. Assistant United States Attorney Seth A. Nielsen will prosecute.

This prosecution falls under the Homeland Security Task Force initiative established by Executive Order 14159 aimed at combating criminal cartels, transnational organizations, human smuggling rings, and other violent crime groups operating domestically or abroad through interagency collaboration involving agencies such as Homeland Security Investigations (HSI), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), Federal Bureau of Investigation (FBI), Drug Enforcement Administration (DEA), with prosecution led by United States Attorney’s Office for Utah.

An indictment is an allegation; all defendants are presumed innocent until proven guilty beyond reasonable doubt in court.

The U.S. Attorney’s Office for the District of Utah enforces federal laws across all counties in Utah—including areas covering five national parks—and operates offices in Salt Lake City and St. George while advancing community safety initiatives through victim assistance programs with about 85 employees including 45 assistant attorneys under its jurisdiction within the Department of Justice, according to its official website.

Filed Under

Share This Story

X / Twitter
LinkedIn
Email
Print

Advertisement

300 × 250

Related

DEA Details Ongoing Operations Against CJNG Cartel

Daily Dispatch

The morning briefing on federal government — delivered to your inbox before 7 AM.

Advertisement

300 × 120

More from Defense

Washington National Guard Continues Statewide Wildfire Response

The Washington National Guard continued deploying air and ground assets across the state on Aug. 10 as multiple wildfires burned simultaneously in the Pacific Northwest. Federal active-duty forces from Joint...

OCC Signals Push to Revive New Bank Charter Applications

The Office of the Comptroller of the Currency announced on Aug. 11 that it will prioritize new bank charter applications as part of a “community bank comeback” initiative. The effort...

FDA Approves First Oral PCSK9 Inhibitor to Lower Cholesterol

The FDA approved the first oral PCSK9 inhibitor for lowering LDL cholesterol in adults on July 17, removing a major barrier to broader use of the most powerful class of...